Young Mania Rating Scale (YMRS)

Abstract

The Young Mania Rating Scale (YMRS) is an 11-item clinician-administered assessment instrument designed to measure the severity of manic states in patients with bipolar disorder and related affective illnesses. Introduced in 1978 by Robert C. Young, John T. Biggs, Vincent E. Ziegler, and Donald A. Meyer, the YMRS has become the international gold standard in psychiatric research and clinical trials evaluating antimanic pharmacotherapies and psychotherapeutic interventions. The scale combines a patient’s subjective self-report over the preceding 48 hours with direct behavioral observation by a trained clinician during a 15- to 30-minute semi-structured clinical interview. Structurally, the instrument assesses 11 distinct clinical domains: elevated mood, increased motor activity/energy, sexual interest, sleep, irritability, rate and amount of speech, language/thought disorder, thought content, disruptive/aggressive behavior, appearance, and insight. Seven items are evaluated on a 5-point Likert-type anchor scale (0 to 4), while four items (irritability, speech, thought content, and disruptive/aggressive behavior) are double-weighted on a 9-point anchor scale (0 to 8, in two-point increments) to compensate for common patient uncooperativeness or guardedness during acute manic episodes. Total scores range from 0 to 60. Extensive psychometric evaluations demonstrate excellent inter-rater reliability ($r = 0.93$), high internal consistency (Cronbach’s $\alpha = 0.80\text{–}0.91$), robust convergent validity with the Bech-Rafaelsen Mania Scale ($r = 0.90$), and acute sensitivity to therapeutic change over time. Although the scale does not align completely with contemporary DSM-5 diagnostic criteria for mania—lacking explicit operationalization for distractibility, discrete goal-directed activity, and risk-laden pleasure-seeking—it remains an indispensable psychometric index of manic syndrome severity.

Keywords

Young Mania Rating Scale, YMRS, Bipolar Disorder, Mania, Psychometrics, Affective Disorders, Clinical Assessment, Inter-Rater Reliability, Factor Analysis, Mood Disorders, Severity Rating Scale, Antimanic Efficacy

Authors

The Young Mania Rating Scale was devised and validated by a team of clinical psychiatric researchers at the Washington University School of Medicine in St. Louis, Missouri, and the New York Hospital-Cornell Medical Center:

• Robert C. Young, M.D. — Department of Psychiatry, Cornell University Medical College, New York Hospital-Westchester Division, White Plains, New York. Dr. Young served as the principal investigator in conceptualizing the clinical weighting and observational criteria for the scale.
• John T. Biggs, M.D. — Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri. Renowned for clinical psychopharmacology and research methodology in affective disorders.
• Vincent E. Ziegler, M.D. — Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri. Contributed extensively to early psychotropic drug monitoring and mood assessment validation.
• Donald A. Meyer, M.D. — Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri. Collaborated on inpatient observational methodologies and inter-rater reliability protocols.

Purpose

The primary clinical and psychometric purpose of the Young Mania Rating Scale (YMRS) is to quantify the severity of manic symptomatology in adolescent and adult populations over a defined, acute observation period (conventionally the preceding 48 hours). The scale was conceived to resolve critical methodological limitations present in earlier assessment batteries, such as the Mania Rating Scale (Beigel et al., 1971), which relied on protracted nursing observation over an 8-hour shift and lacked rapid clinician applicability in controlled clinical drug trials.

The YMRS was developed specifically as an outcome measure rather than a categorical diagnostic instrument. While diagnostic classifications such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) delineate whether a patient meets the threshold criteria for a Bipolar I Manic Episode, the YMRS tracks the continuum of symptom magnitude, monitoring both subtle escalations in hypomania and profound elevations in psychotic mania. This makes it suitable for:

• Phase III and Phase IV Pharmacological Trials: Evaluating the rapid antimanic efficacy of mood stabilizers (e.g., lithium, valproate) and second-generation atypical antipsychotics (e.g., olanzapine, quetiapine, aripiprazole).
• Inpatient Psychiatric Monitoring: Tracking patient trajectory toward behavioral stabilization, discharge readiness, and pharmacotherapeutic response.
• Outpatient Relapse Identification: Screening for early prodromal breakthrough symptoms or emergent switch from unipolar/bipolar depression into hypomania or mixed states.
• Differential Diagnosis Research: Differentiating primary manic mood escalation from secondary hyperactivity, such as severe adult or pediatric Attention-Deficit/Hyperactivity Disorder (ADHD), and from agitated states in schizoaffective disorder or schizophrenia.

A core rationale of the YMRS is its integration of dual informational channels: patient self-reporting regarding internal affective and vegetative shifts (such as decreased need for sleep or subjective hypersexuality) combined with the clinician’s objective observation of overt speech cadence, behavioral disruption, psychomotor agitation, and thought structure during the evaluation. Because mania is characterized by cognitive distortion, grandiosity, and impaired reality testing, relying purely on self-report instruments introduces significant measurement error. The YMRS addresses this through observer-rated anchor points and double-weighted scoring on dimensions that patients frequently minimize or conceal.

Psychological Construct

The psychological construct evaluated by the YMRS is the multifaceted clinical syndrome of mania. Historically conceptualized as an episodic disorder of mood, modern psychometrics recognizes mania as a complex neuropsychiatric disturbance characterized by psychomotor activation, accelerated cognition, emotional lability, dysregulated neurovegetative rhythms, and behavioral disinhibition. The YMRS operationalizes this construct across 11 interrelated domains:

1. Elevated Mood

This dimension examines affective valence, ranging from baseline euthymia to sustained euphoria. At lower anchor points, the individual displays cheerful optimism and self-confidence appropriate to contextual cues. As severity progresses, the affective elevation detaches from reality, manifesting as inappropriate humor, inappropriate laughter, singing, and infectious or bizarrely disconnected euphoria.

2. Increased Motor Activity or Energy

This subscale assesses psychomotor activation, motor restlessness, and behavioral energy. Manifestations progress from subjective sensations of boundless energy to objective physical agitation, hyper-gestural presentation, continuous pacing, and uncontainable motor excitement where the individual cannot be calmed or seated.

3. Sexual Interest

Hypersexuality is a hallmark vegetative and instinctual feature of mania. The scale assesses shifts in libido, spanning mild subjective increases, spontaneous and uninhibited sexual references during conversation, active hypersexual solicitation, and overt, socially inappropriate sexual behaviors.

4. Sleep Reduction

Rather than assessing traditional insomnia (where sleep is desired but unattained), this construct evaluates the reduced need for sleep, reflecting disrupted circadian and monoaminergic homeostasis. The construct progresses from sleeping an hour less than normal to a profound neurovegetative state in which the individual experiences boundless energy despite zero hours of sleep.

5. Irritability

Manic episodes are often characterized by dysphoria and hostility rather than pure euphoria. This double-weighted dimension measures affective reactivity, impatience, and anger. Severities advance from subjective irritability to overt verbal snaps, explosive episodes of hostility, and absolute refusal to cooperate with clinical assessment.

6. Rate and Amount of Speech

Reflecting accelerated central nervous system processing and psychomotor pressure, this double-weighted construct monitors logorrhea and pressured speech. Levels escalate from talkativeness to continuous verbal production, heightened volume, rapid cadence, and ultimately unbroken, pressured speech that resists interruption by the interviewer.

7. Language and Thought Disorder

This construct examines formal thought disorder. It charts the loss of goal-directed associative thinking, spanning circumstantiality and tangentiality, distractibility, racing thoughts, overt flight of ideas, clang associations, rhyming, echolalia, and profound cognitive fragmentation resulting in incoherence.

8. Thought Content

Investigating the cognitive content of mania, this double-weighted item assesses the progression of grandiosity and reality distortions. Symptoms range from unrealistic professional or creative ventures to intense religiosity, ideas of reference, persecutory/paranoid ideas, and systematized grandiose or somatic delusions.

9. Disruptive or Aggressive Behavior

This double-weighted construct measures the externalization of behavioral disinhibition. Ratings scale from sarcasm, guardedness, and elevated vocal volume to direct verbal threats, destruction of property, physical assault, and severe behavioral volatility requiring physical or pharmacological containment.

10. Appearance

This domain serves as an objective marker of grooming, cognitive organization, and decorum. Pathological variations include subtle dishevelment, flamboyant or hyper-ornamented clothing, garish makeup, partially disrobed states, and bizarre, idiosyncratic adornments reflecting disorganized behavior.

11. Insight

Anosognosia, or the lack of awareness of illness, is central to the morbidity of bipolar mania. This construct measures the patient’s ability to acknowledge psychological distress, recognize psychiatric illness, and accept the necessity of pharmacological intervention, scaling to total denial of any behavioral abnormality.

Theoretical Framework

The Young Mania Rating Scale is grounded in classical European and North American psychiatric traditions, integrating concepts of manic-depressive illness from Emil Kraepelin, Adolf Meyer, and the Washington University School of Medicine diagnostic school (the Feighner Criteria and subsequent Research Diagnostic Criteria). Kraepelinian nosology posited that affective disorders comprise periodic, sweeping disruptions across three interdependent psychic spheres: affect (mood), intellect (thought processes), and volition (motor activity). The 11 items of the YMRS map systematically onto this Kraepelinian triad:

• Affective Sphere: Operationalized through Items 1 (Elevated Mood) and 5 (Irritability).
• Intellectual Sphere: Operationalized through Items 6 (Speech Rate/Amount), 7 (Language/Thought Disorder), 8 (Thought Content), and 11 (Insight).
• Volitional/Motor Sphere: Operationalized through Items 2 (Motor Activity/Energy), 3 (Sexual Interest), 4 (Sleep), 9 (Aggressive Behavior), and 10 (Appearance).

From a modern neurobiological and cognitive perspective, the YMRS aligns with the Behavioral Approach System (BAS) Dysregulation Model developed by Depue and Iacono (1989) and expanded by Alloy and Abramson (2010). Under the BAS framework, mania represents a hyper-reactive reward-processing state characterized by excessive dopaminergic neurotransmission in frontostriatal circuits. Individuals encountering goal-striving or reward-relevant stimuli experience an uncontrollable surge in behavioral activation, optimism, and energy. The YMRS captures these behavioral manifestations through its indices of grandiosity, uninhibited drive, reduced need for sleep, and impulsivity.

The instrument also integrates clinical psychometric assumptions established by Max Hamilton during the construction of the Hamilton Rating Scale for Depression (HAM-D). Young and colleagues recognized that severe psychiatric pathology cannot be assessed adequately using equal-interval unweighted scales if certain behaviors impede the evaluation itself. Patients experiencing acute mania often exhibit profound irritability, flight of ideas, paranoia, or disruptive behavior, leading to guarded, incomplete, or hostile self-reporting. To counter this, Young et al. instituted a differential weighting framework: four core items that reflect acute behavioral severity and resistance to examination (Irritability, Speech, Content, Aggression) are scaled from 0 to 8, while the remaining seven items are scaled from 0 to 4. This ensures that behavioral disruption receives sufficient mathematical weight in the total score, preventing an uncooperative or combative manic patient from appearing low-scoring due to non-response.

Validity

The psychometric validity of the YMRS has been demonstrated across clinical trials, inpatient cohorts, and diverse cross-cultural settings.

Construct and Criterion Validity

The construct validity of the scale was established in the original validation study by Young et al. (1978) utilizing a cohort of 20 psychiatric inpatients with primary affective disorders. The scale distinguished manic patients from depressed and non-affective controls. In a series of criterion-related validation trials, the YMRS showed sensitivity to longitudinal clinical shifts. Total scores decreased systematically following therapeutic interventions, with significant score differentiation observed between baseline assessment and follow-up after two weeks of treatment ($p < 0.001$).

Convergent Validity

Convergent validity has been established through comparisons with established clinician-administered mania instruments:

• Bech-Rafaelsen Mania Scale (BRMS): Concurrent validity correlations between the YMRS and the BRMS are consistently high, ranging from $r = 0.85$ to $r = 0.90$ ($p < 0.001$), confirming that both instruments assess a shared clinical construct (Wciorka et al., 2011).
• Petterson Mania Scale: Initial investigations documented strong correlations ($r = 0.89$) between clinician YMRS ratings and independent Petterson scale scores.
• Clinical Global Impressions – Bipolar Version (CGI-BP): Research demonstrates strong positive correlations between the YMRS total score and the CGI-BP mania severity subscale ($r = 0.76\text{–}0.88$).

Discriminant Validity

The YMRS demonstrates discriminant validity in differentiating mania from other psychiatric conditions with overlapping symptoms:

• ADHD vs. Bipolar Mania: In pediatric and adolescent cohorts, the Parent-version (P-YMRS) and clinical YMRS reliably discriminate pediatric mania from severe ADHD, specifically via elevated scores on grandiosity, decreased need for sleep, hypersexuality, and flight of ideas, which are rare in pure ADHD (Serrano et al., 2011).
• Schizophrenia and Schizoaffective Disorder: Research by Seon-Cheol and Joonjo (2016) demonstrated that while psychotic symptoms appear in both conditions, the affective clustering (euphoria, decreased sleep need, unprompted sexual content) captured by the YMRS differentiates manic excitement from catatonic or disorganized excitement in schizophrenia.

Cutoff Scores and Clinical Stratification

Analyses from large-scale naturalistic studies, including the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study (Lukasiewicz et al., 2013), have established validated severity cutoffs and treatment response metrics:

• Total Score $le 12$: Remission / Euthymia
• Total Score $13\text{–}19$: Minimal or Mild Manic Symptoms (often indicative of Hypomania)
• Total Score $20\text{–}25$: Moderate Mania
• Total Score $ge 26$ to $38$: Severe Mania
• Total Score $ge 39$: Extremely Severe / Psychotic Mania
• Clinical Response: A $ge 50%$ reduction in baseline total score is the standard benchmark for clinical response in randomized controlled trials.

Reliability

The YMRS displays high reliability across clinical and research environments, maintaining measurement stability across diverse rater groups:

Inter-Rater Reliability

In their seminal paper, Young et al. (1978) reported an overall inter-rater reliability coefficient of $r = 0.93$ for total scores based on simultaneous, independent interviews conducted by two clinicians. Individual item-level inter-rater agreement was consistently high, ranging from $r = 0.66$ (Insight) to $r = 0.92$ (Speech Rate and Amount). Subsequent evaluations confirmed intra-class correlation coefficients (ICCs) between $0.88$ and $0.96$ across trained psychiatrists, psychiatric nurses, and clinical research coordinators.

Internal Consistency

The internal consistency of the scale has been replicated in various clinical environments. Cronbach’s alpha ($\alpha$) coefficients range between $0.80$ and $0.91$. For example, an EMBLEM validation cohort of over 3,000 patients reported an alpha of $0.88$. These values confirm substantial item interrelatedness without redundancy, showing that each of the 11 items contributes distinct psychometric variance to the construct.

Test-Retest Reliability

Because acute mania is an unstable, fluctuating clinical syndrome sensitive to medication, evaluating classic long-term test-retest reliability can confound symptom change with measurement error. However, short-interval test-retest reliability (evaluating patients across a 24- to 48-hour window without pharmacologic modification) shows stability, with Pearson correlation coefficients consistently exceeding $r = 0.82$.

Factor Analysis

Numerous exploratory factor analyses (EFA) and confirmatory factor analyses (CFA) have examined whether the YMRS is strictly unidimensional or comprises distinct symptom sub-dimensions. The literature generally supports a multi-factorial structure that converges around two to four principal dimensions:

Two-Factor Models

Early factorial studies identified a bifurcated symptom structure:

1. Core Manic / Hyperactive Factor: Comprising elevated mood, increased energy/motor activity, pressured speech, hypersexuality, and decreased sleep. This represents classical euphoric hypomanic/manic drive.
2. Psychotic / Disruptive Factor: Comprising irritability, thought content (delusions/paranoia), disruptive/aggressive behavior, thought disorder, and lack of insight. This captures dysphoric, agitated, or psychotic mania.

Three-Factor Models

More granular structural evaluations (e.g., Haro et al., 2011; EMBLEM study) provide support for a 3-factor latent model, yielding improved goodness-of-fit indices (CFI > 0.94, RMSEA < 0.06):

• Factor 1: Elated/Hyperactive Dimension (Items 1, 2, 3, 4, 6) — High loadings for elevated affect, physical activation, hypersexuality, reduced sleep, and speech output.
• Factor 2: Irritable/Aggressive Dimension (Items 5, 9) — High loadings for irritability and disruptive/aggressive behavioral patterns.
• Factor 3: Psychotic/Cognitive Disorganization Dimension (Items 7, 8, 10, 11) — Substantial factor loadings for thought disorder, delusional content, bizarre grooming/appearance, and impaired clinical insight.

Factor loading values for primary items across literature typically exceed $lambda = 0.55$, with speech and energy frequently loading across both affective and behavioral factors. This factor architecture supports the practice of reporting both the aggregate composite score (0 to 60) and specific dimensional subscores, particularly when assessing whether a treatment targets core euphoric symptoms, psychotic phenomena, or behavioral dyscontrol.

Instrument / Measurement Tool

• Instrument Name: Young Mania Rating Scale (YMRS)
• Original Publication Date: 1978
• Authors: Robert C. Young, John T. Biggs, Vincent E. Ziegler, and Donald A. Meyer
• Instrument Type: Clinician-administered, observer-rated severity rating scale
• Primary Target Construct: Severity of acute manic and hypomanic states
• Total Number of Items: 11 items
• Administration Time: Approximately 15 to 30 minutes
• Information Baseline: Synthesis of patient self-report across the past 48 hours and clinical observation during interview
• Structure and Scoring Rules:
  • Standard Weighted Items (7 items): Graded on a 5-point scale (0, 1, 2, 3, 4).
    • Item 1: Elevated Mood
    • Item 2: Increased Motor Activity or Energy
    • Item 3: Sexual Interest
    • Item 4: Sleep
    • Item 7: Language: Thought Disorder
    • Item 10: Appearance
    • Item 11: Insight
  • Double-Weighted Items (4 items): Graded on a 9-point anchor scale with 2-point increments (0, 2, 4, 6, 8) to compensate for guardedness or lack of cooperation:
    • Item 5: Irritability
    • Item 6: Speech: Rate & Amount
    • Item 8: Content
    • Item 9: Disruptive or Aggressive Behavior
  • Intermediate Scoring: Half-point scores or intermediate ratings (e.g., 1, 3, 5, 7 on double-weighted items) are permissible if clinical presentation falls between descriptive anchor points.
  • Total Score Range: 0 to 60 points, calculated as the direct sum of all 11 items.
• Clinical Severity Interpretation:
  • 0 to 12: Euthymia / Remission
  • 13 to 19: Minimal / Mild Mania (often Hypomania)
  • 20 to 25: Moderate Mania
  • 26 to 38: Severe Mania
  • 39 to 60: Extremely Severe / Psychotic Mania

Permissions & Fee and Test Year

The Young Mania Rating Scale was originally published in 1978 in the British Journal of Psychiatry (Young, Biggs, Ziegler, & Meyer, 1978). The scale is widely considered to be in the public domain for academic, clinical, and non-commercial educational use. Clinicians and independent researchers may administer, reproduce, and score the YMRS without paying licensing fees or royalties, provided appropriate bibliographic citation is maintained. However, commercial entities, including pharmaceutical sponsors conducting registered clinical trials and digital healthcare platforms integrating the YMRS into proprietary software, may require formal clearance or permissions depending on institutional and publisher policies. A self-administered version also exists, but caution is warranted regarding its validity, as severe manic presentations inherently impair self-reflection and insight.

References

• Alloy, L. B., & Abramson, L. Y. (2010). The behavioral approach system, the behavioral inhibition system, and bipolar spectrum disorders: Review and synthesis. Clinical Psychology Review, 30(6), 668–684. https://doi.org/10.1016/j.cpr.2010.05.001
• Beigel, A., Murphy, D. L., & Bunney, W. E., Jr. (1971). The Manic-State Rating Scale: Scale construction, reliability, and validity. Archives of General Psychiatry, 25(3), 256–262. https://doi.org/10.1001/archpsyc.1971.01750150064010
• Depue, R. A., & Iacono, W. G. (1989). Neurobehavioral aspects of affective disorders. Annual Review of Psychology, 40(1), 457–492. https://doi.org/10.1146/annurev.ps.40.020189.002325
• Haro, J. M., Kamath, V. P., Ochoa, S., Novick, D., Rele, E., Fargas, A., & Rodriguez, M. (2011). The EMBLEM study: 2-year results of an observational study of bipolar disorder in Europe. Journal of Affective Disorders, 131(1–3), 238–246. https://doi.org/10.1016/j.jad.2010.12.007
• Lukasiewicz, M., Gerard, S., Besnard, A., Falissard, B., Perrin, E., Sapin, H., Tohen, M., Reed, C., Azorin, J.-M., & The EMBLEM Study Group. (2013). Young Mania Rating Scale: How to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. International Journal of Methods in Psychiatric Research, 22(1), 46–58. https://doi.org/10.1002/mpr.1379
• Miller, C. J., Johnson, S. L., & Eisner, L. (2009). Assessment tools for adult bipolar disorder. Clinical Psychology: Science and Practice, 16(2), 188–201. https://doi.org/10.1111/j.1468-2850.2009.01158.x
• Seon-Cheol, P., & Joonjo, C. (2016). Using the Young Mania Rating Scale for identifying manic symptoms in patients with schizophrenia. Yonsei Medical Journal, 57(5), 1298–1299. https://doi.org/10.3349/ymj.2016.57.5.1298
• Serrano, E., Ezpeleta, L., Alda, J., Matalí, J., & San, L. (2011). Psychometric properties of the Young Mania Rating Scale for the identification of mania symptoms in Spanish children and adolescents with attention deficit/hyperactivity disorder. Psychopathology, 44(2), 125–132. https://doi.org/10.1159/000319349
• Wciorka, J., Schaeffer, E., Switaj, P., Waszkiewicz, J., Krasuska, K., Wegrzyn, J., & Wozniak, P. (2011). Bech-Rafaelsen Mania Scale and Young Mania Rating Scale—comparison of psychometric properties of the two instruments for rating a manic syndrome. Psychiatria Polska, 45(1), 61–78.
• Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journal of Psychiatry, 133(5), 429–435. https://doi.org/10.1192/bjp.133.5.429

13. Items of the Scale (Questionnaire)